FAZDI Trademark

Trademark Overview

On Thursday, October 15, 2020, a trademark application was filed for FAZDI with the United States Patent and Trademark Office. The USPTO has given the FAZDI trademark a serial number of 90257584. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, May 10, 2024. This trademark is owned by Eagle Pharmaceuticals Inc.. The FAZDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer
fazdi

General Information

Serial Number90257584
Word MarkFAZDI
Filing DateThursday, October 15, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, May 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2021

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEagle Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677
Party NameEagle Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677

Trademark Events

Event DateEvent Description
Monday, October 19, 2020NEW APPLICATION ENTERED
Thursday, December 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021PRIORITY ACTION WRITTEN
Wednesday, February 3, 2021PRIORITY ACTION E-MAILED
Wednesday, February 3, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, August 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 12, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 6, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 6, 2022SOU EXTENSION 1 FILED
Monday, June 6, 2022SOU EXTENSION 1 GRANTED
Wednesday, June 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 7, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 7, 2022SOU EXTENSION 2 FILED
Wednesday, December 7, 2022SOU EXTENSION 2 GRANTED
Friday, December 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 5, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 5, 2023SOU EXTENSION 3 FILED
Monday, June 5, 2023SOU EXTENSION 3 GRANTED
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Wednesday, June 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 28, 2023SOU EXTENSION 4 FILED
Thursday, September 28, 2023SOU EXTENSION 4 GRANTED
Saturday, September 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 10, 2024SOU EXTENSION 5 GRANTED
Friday, May 10, 2024SOU EXTENSION 5 FILED
Saturday, May 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

fazdi cancer treatment pharmaceuticals